Human Immunodeficiency Virus–Associated Primary Lung Cancer in the Era of Highly Active Antiretroviral Therapy: A Multi-Institutional Collaboration
Authors:
- Liron PantanowitzLPLiron Pantanowitz
- Mark BowerMBMark Bower
- Susan BuskinSBSusan Buskin
- Nancy NeilNNNancy Neil
- Erin M. GrecoEGErin M. Greco
- Timothy P. CooleyTCTimothy P. Cooley
- David HenryDHDavid Henry
- Jonathan StemJSJonathan Stem
- Bruce J. DezubeBDBruce J. Dezube
- Justin StebbingJSJustin Stebbing
- David M. AboulafiaDADavid M. Aboulafia
- 1 November 2010
- journal article
- Published by Elsevier in Clinical Lung Cancer
- Vol. 11 (6) , 396-404
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- A Meta-Analysis of the Incidence of Non-AIDS Cancers in HIV-Infected IndividualsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort studyThe Lancet Oncology, 2009
- Decreased TIP30 Expression Promotes Tumor Metastasis in Lung CancerThe American Journal of Pathology, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Trends in perimortal conditions and mortality rates among HIV-infected patientsAIDS, 2007
- Lung cancer, a new challenge in the HIV-infected populationLung Cancer, 2006
- Protease inhibitors potentiate chemotherapy-induced neutropeniaBlood, 2004
- HIV-related lung cancer in the era of highly active antiretroviral therapyAIDS, 2003
- The stressors and stress of being HIV-positiveAIDS Care, 1996
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958